United Kingdom· GB-APID-34881811000001106
Nulbia 5% cream
A medicinal product containing lidocaine + prilocaine, registered in United Kingdom by Glenmark Pharmaceuticals Europe Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Lidocaine + Prilocaine
- Manufacturer
- Glenmark Pharmaceuticals Europe Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5060204163951
- gtin5060204163982
- gtin5060204163944
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lidocaine + prilocaine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAnesdermInPharm Sp. z o.o.
- United StatesCadira Compliant Blood StatAsclemed USA, Inc.
- SwitzerlandAnesderm
- FranceANESDERM 5 %, crèmePIERRE FABRE MEDICAMENT
- SwedenEMLA 25 mg/25 mg Medicinskt plåsterAspen Pharma Trading Limited
- FinlandEmlaOrifarm Oy
- CzechiaEMLAAspen Pharma Trading Limited, Dublin
- SpainANAMAP 25 MG/G + 25 MG/G CREMAGlenmark Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Emla, Emla Pflaster
- Belgium · Emla, Emla Patch
- Cyprus · Emla, Xylocream
- Czechia · Emla
- Germany · Anesderm, Emla
- Denmark · Emla, Lidocain/Prilocain Idd
- Estonia · Nulbia
- Spain · Anamap®, Anestderma
- Finland · Emla, Oraqix
- France · Anesderm, Emla
- Greece · Emla, Nulbia
- Hungary · Li-Pri
- Ireland · Emla, Oraqix
- Iceland · Emla, Fortacin
- Italy · Emla, Lidocaina E Prilocaina Teva
- Liechtenstein · Fortacin
- Luxembourg · Emla, Emla Patch
- Malta · Emla, Opralix
- Netherlands · Emla, Lidocaïne/Prilocaïne Teva
- Norway · Emla, Fortacin
- Poland · Anesderm, Emla
- Portugal · Emla, Emla Penso
- Romania · Romla
- Sweden · Emla, Oraqix
- Slovakia · Romla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a3d9c4b-eb7f-4ea2-a8af-4794528dea24 GET /v1/drugs/2a3d9c4b-eb7f-4ea2-a8af-4794528dea24?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34881811000001106",
"desc": "Nulbia 5% cream (Glenmark Pharmaceuticals Europe Ltd)",
"form": "Cutaneous cream",
"vpid": "41902311000001109",
"source": "dmd",
"vtm_id": "776533008",
"strength": "25 mg",
"substance": "Lidocaine + Prilocaine",
"ingredient": "Lidocaine",
"supplier_code": "15537011000001107"
}See everything about lidocaine + prilocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.